Multi-country study on the prevalence and clinical features of peripheral arterial disease in asian type 2 diabetes patients at high risk of atherosclerosis

Diabetes Research and Clinical Practice

Volumn 76, Issue 1, 2007, Pages 82-92

  Rhee, Sang Youl ^a   Guan, Heng ^b   Liu, Zhi Min ^c   Cheng, Stephen Wing Keung ^d   Waspadji, Sarwono ^e   Palmes, Patricio ^f   Tai, Tong Yuan ^g   Suwanwalaikorn, Sompongse ^h   Kim, Young Seol ^a  

^a Kyung Hee University Hospital   (South Korea)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^f WEST VISAYAS STATE UNIVERSITY   (Philippines)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Asia; Diabetes complications; Diabetes mellitus; Epidemiology; Peripheral vascular diseases; Risk factors

Indexed keywords

LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ASIAN; CARDIOVASCULAR RISK; CHINA; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; DEMOGRAPHY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HONG KONG; HUMAN; HYPERTENSION; INDONESIA; KOREA; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHILIPPINES; PREVALENCE; PULSE WAVE; RISK ASSESSMENT; SAMPLE SIZE; SCREENING TEST; SEX DIFFERENCE; TAIWAN; THAILAND; TRIACYLGLYCEROL BLOOD LEVEL;

AGE DISTRIBUTION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDIES; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 33846920360     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.07.029     Document Type: Article

References (28)

1. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
2. Yanovski S.Z., and Yanovski J.A. Obesity. N. Engl. J. Med. 346 (2002) 591-602
3. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
4. Fuster V., and Gotto Jr. A.M. Risk reduction. Circulation 102 (2000) IV94-IV102
5. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
6. McDermott M.M., Kerwin D.R., Liu K., Martin G.J., O'Brien E., Kaplan H., et al. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J. Gen. Intern. Med. 16 (2001) 384-390
7. Newman A.B., Siscovick D.S., Manolio T.A., Polak J., Fried L.P., Borhani N.O., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993) 837-845
8. Leng G.C., Lee A.J., Fowkes F.G., Whiteman M., Dunbar J., Housley E., et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 25 (1996) 1172-1181
9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497.
10. Smith F.B., Lowe G.D., Lee A.J., Rumley A., Leng G.C., and Fowkes F.G. Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication. J. Vasc. Surg. 28 (1998) 129-135
11. Fowkes F.G., Housley E., Riemersma R.A., Macintyre C.C., Cawood E.H., Prescott R.J., et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am. J. Epidemiol. 135 (1992) 331-340
12. Hooi J.D., Stoffers H.E., Kester A.D., Rinkens P.E., Kaiser V., van Ree J.W., et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand. J. Prim. Health Care 16 (1998) 177-182
13. Lowe G.D., Fowkes F.G., Dawes J., Donnan P.T., Lennie S.E., and Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 87 (1993) 1915-1920
14. Murabito J.M., D'Agostino R.B., Silbershatz H., and Wilson W.F. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 96 (1997) 44-49
15. Leibson C.L., Ransom J.E., Olson W., Zimmerman B.R., O'Fallon W.M., and Palumbo P.J. Peripheral arterial disease, diabetes, and mortality. Diabetes Care 27 (2004) 2843-2849
16. Gregg E.W., Sorlie P., Paulose-Ram R., Gu Q., Eberhardt M.S., Wolz M., et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 27 (2004) 1591-1597
17. Dolan N.C., Liu K., Criqui M.H., Greenland P., Guralnik J.M., Chan C., et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25 (2002) 113-120
18. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N. Engl. J. Med. 344 (2001) 1608-1621
19. Kubo T., Miyata M., Minagoe S., Setoyama S., Maruyama I., and Tei C. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens. Res. 25 (2002) 351-358
20. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of non-invasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 25 (2002) 359-364
21. Weisell R.C. Body mass index as an indicator of obesity. Asia Pac. J. Clin. Nutr. 11 Suppl. 8 (2002) S681-S684
22. Meijer W.T., Hoes A.W., Rutgers D., Bots M.L., Hofman A., and Grobbee D.E. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 185-192
23. Gofin R., Kark J.D., Friedlander Y., Lewis B.S., Witt H., Stein Y., et al. Peripheral vascular disease in a middle-aged population sample. The Jerusalem Lipid Research Clinic Prevalence Study. Isr. J. Med. Sci. 23 (1987) 157-167
24. Criqui M.H., Fronek A., Barrett-Connor E., Klauber M.R., Gabriel S., and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985) 510-515
25. O'Rourke M.F., Pauca A., and Jiang X.J. Pulse wave analysis. Br. J. Clin. Pharmacol. 51 (2001) 507-522
26. Tseng C.H. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 54 (2003) 331-338
27. Uusitupa M.I., Niskanen L.K., Siitonen O., Voutilainen E., and Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation 82 (1990) 27-36
28. MacGregor A.S., Price J.F., Hau C.M., Lee A.J., Carson M.N., and Fowkes F.G. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study. Diabetes Care 22 (1999) 453-458